Fibril formation from recombinant human serum amyloid A

Author(s):  
Toshiyuki Yamada ◽  
Barbara Kluve-Beckerman ◽  
Juris J. Liepnieks ◽  
Merrill D. Benson
Amyloid ◽  
2016 ◽  
Vol 23 (2) ◽  
pp. 67-75 ◽  
Author(s):  
Hiroka Takase ◽  
Masafumi Tanaka ◽  
Aki Yamamoto ◽  
Shiori Watanabe ◽  
Sanae Takahashi ◽  
...  

2017 ◽  
Vol 202 ◽  
pp. 6-12 ◽  
Author(s):  
Masafumi Tanaka ◽  
Ayaka Nishimura ◽  
Haruka Takeshita ◽  
Hiroka Takase ◽  
Toshiyuki Yamada ◽  
...  

2018 ◽  
Vol 639 ◽  
pp. 9-15 ◽  
Author(s):  
Masafumi Tanaka ◽  
Toru Kawakami ◽  
Nozomi Okino ◽  
Kaoru Sasaki ◽  
Kiwako Nakanishi ◽  
...  

2021 ◽  
pp. 100080
Author(s):  
Martyna Maszota-Zieleniak ◽  
Annemarie Danielsson ◽  
Sergey A. Samsonov

1991 ◽  
pp. 20-23
Author(s):  
A. Steinmetz ◽  
H. Vitt ◽  
S. Motzny ◽  
H. Kaffarnik

1989 ◽  
Vol 263 (2) ◽  
pp. 365-370 ◽  
Author(s):  
A F Strachan ◽  
E G Shephard ◽  
D U Bellstedt ◽  
G A Coetzee ◽  
D R van der Westhuyzen ◽  
...  

Human serum amyloid A protein (apo-SAA) can be prepared by gel filtration of delipidated acute-phase high-density lipoprotein in the presence of urea. The resultant apo-SAA is soluble (greater than 90% solubility) in a wide range of buffer solutions, with all of the six major isoforms of apo-SAA being equally soluble. In urea-containing solutions the isoforms behave qualitatively differently in various urea concentrations, probably reflecting subtle primary-structure variations. The higher-pI isoforms are only completely unfolded at greater than 7 M-urea. By immunizing with apo-SAA adsorbed to acid-treated bacteria (Salmonella minnesota R595), high-titre antibodies can easily be elicited in rabbits.


2014 ◽  
Vol 444 (1) ◽  
pp. 92-97 ◽  
Author(s):  
Hiroka Takase ◽  
Masafumi Tanaka ◽  
Sachiko Miyagawa ◽  
Toshiyuki Yamada ◽  
Takahiro Mukai

Sign in / Sign up

Export Citation Format

Share Document